These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34959440)

  • 1. Improving the Physicochemical and Biopharmaceutical Properties of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicine through Cocrystal Engineering.
    Guan D; Xuan B; Wang C; Long R; Jiang Y; Mao L; Kang J; Wang Z; Chow SF; Zhou Q
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocrystallization of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicines.
    Guo H; Liu S
    Chem Pharm Bull (Tokyo); 2023; 71(5):326-333. PubMed ID: 37121683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocrystal and its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients.
    Wang N; Xie C; Lu H; Guo N; Lou Y; Su W; Hao H
    Curr Pharm Des; 2018; 24(21):2339-2348. PubMed ID: 29788878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Pharmaceutical Cocrystals: A Focused Review of Flavonoid Cocrystals.
    Xu J; Shi Q; Wang Y; Wang Y; Xin J; Cheng J; Li F
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems.
    Singh M; Barua H; Jyothi VGSS; Dhondale MR; Nambiar AG; Agrawal AK; Kumar P; Shastri NR; Kumar D
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications.
    Guo M; Sun X; Chen J; Cai T
    Acta Pharm Sin B; 2021 Aug; 11(8):2537-2564. PubMed ID: 34522597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.
    Panzade PS; Shendarkar GR
    Curr Drug Deliv; 2017; 14(8):1097-1105. PubMed ID: 27758692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances on the Biological Study of Pharmaceutical Cocrystals.
    Wang Z; Xie Y; Yu M; Yang S; Lu Y; Du G
    AAPS PharmSciTech; 2022 Nov; 23(8):303. PubMed ID: 36396736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental cocrystal screening and solution based scale-up cocrystallization methods.
    Malamatari M; Ross SA; Douroumis D; Velaga SP
    Adv Drug Deliv Rev; 2017 Aug; 117():162-177. PubMed ID: 28811184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.
    Karagianni A; Malamatari M; Kachrimanis K
    Pharmaceutics; 2018 Jan; 10(1):. PubMed ID: 29370068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals.
    Aitipamula S; Das S
    Eur J Pharm Biopharm; 2020 Apr; 149():95-104. PubMed ID: 32035236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocrystallization: Cutting Edge Tool for Physicochemical Modulation of Active Pharmaceutical Ingredients.
    Kumari N; Ghosh A
    Curr Pharm Des; 2020; 26(38):4858-4882. PubMed ID: 32691702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development.
    Gadade DD; Pekamwar SS
    Adv Pharm Bull; 2016 Dec; 6(4):479-494. PubMed ID: 28101455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advancements in Pharmaceutical Cocrystals, Preparation Methods, and their Applications.
    Manchanda D; Kumar A; Nanda A
    Curr Pharm Des; 2021; 27(44):4477-4495. PubMed ID: 33858309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocrystals, Salts, and Salt-Solvates of olanzapine; selection of coformers and improved solubility.
    Gong W; Mondal PK; Ahmadi S; Wu Y; Rohani S
    Int J Pharm; 2021 Oct; 608():121063. PubMed ID: 34481007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoconfinement of a Pharmaceutical Cocrystal with Praziquantel in Mesoporous Silica: The Influence of the Solid Form on Dissolution Enhancement.
    Salas-Zúñiga R; Mondragón-Vásquez K; Alcalá-Alcalá S; Lima E; Höpfl H; Herrera-Ruiz D; Morales-Rojas H
    Mol Pharm; 2022 Feb; 19(2):414-431. PubMed ID: 34967632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Dissolution of Naproxen by Combining Cocrystallization and Eutectic Formation.
    Kim H; Jang S; Kim IW
    Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33923065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raman and Terahertz Spectroscopic Characterization of Solid-state Cocrystal Formation within Specific Active Pharmaceutical Ingredients.
    Du Y; Xue J; Hong Z
    Curr Pharm Des; 2020; 26(38):4829-4846. PubMed ID: 32445442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.
    Sathisaran I; Dalvi SV
    Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30065221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.